May 30, 2026
Headlines

Glenmark

Glenmark Pharmaceuticals Reports Massive Q4 Profit Surge Amid Dividend Announcement

Glenmark Pharmaceuticals Reports Massive Q4 Profit Surge Amid Dividend Announcement

Business News Desk03 mins mins

Financial Turnaround Mumbai-based Glenmark Pharmaceuticals Ltd. reported a dramatic financial recovery for the fourth quarter ending March 2026, announcing a net profit of ₹301.4 crore compared to a modest ₹4.6 crore during the same period last year. The pharmaceutical giant revealed these results on May 30, signaling a significant turnaround in its operational efficiency and…

Read More
Glenmark Pharmaceuticals Settles U.S. Generic Drug Pricing Allegations for $29.6 Million

Glenmark Pharmaceuticals Settles U.S. Generic Drug Pricing Allegations for $29.6 Million

Business News Desk03 mins mins

Glenmark Pharmaceuticals’ U.S. subsidiary has agreed to a $29.6 million settlement to resolve long-standing allegations of price-fixing within the generic drug industry. The agreement, announced this week, addresses claims brought by various private litigants who accused the company of participating in a conspiracy to artificially inflate the prices of specific generic medications between 2013 and…

Read More